Skip to main content
Edwards Lifesciences Logo

Acumen IQ cuff

Continuous noninvasive blood pressure and advanced hemodynamic monitoring

References

  1. U.S. Food and Drug Administration. 2021. K203224 510k Summary, Acumen Hypotension Prediction Index.
  2. Kho E, van der Ster BJP, van der Ven WH, Vlaar APJ, Immink RV, Veelo DP. Clinical agreement of a novel algorithm to estimate radial artery blood pressure from the non-invasive finger blood pressure. J Clin Anesth. 2022 Dec;83:110976.
  3. Kouz K, Weidemann F, Naebian A, Lohr A, Bergholz A, Thomsen KK, et al. Continuous Finger-cuff versus Intermittent Oscillometric Arterial Pressure Monitoring and Hypotension during Induction of Anesthesia and Noncardiac Surgery: The DETECT Randomized Trial. Anesthesiology. 2023 Sep 1;139(3):298-308.
  4. Kouz K, Wegge M, Flick M, Bergholz A, Moll-Khosrawi P, Nitzschke R, et al. Continuous intra-arterial versus intermittent oscillometric arterial pressure monitoring and hypotension during induction of anaesthesia: the AWAKE randomised trial. Br J Anaesth. 2022 Oct;129(4):478-486.
  5. Meidert SA, Nold JS, Hornung R, Paulus AC, Zwissler B, Czerner S. The impact of continuous non-invasive arterial blood pressure monitoring on blood pressure stability during general anesthesia in orthopedic patients. Eur J Anaesthesiol. 2017;34:716-722.
  6. Chen G, Chung E, Meng L, Alexander B, Vu T, Rinehart J, et al. Impact of non invasive and beat-to-beat arterial pressure monitoring on intraoperative hemodynamic management. J Clin Monit Comput. 2012 Apr;26(2):133-40.
  7. Kouz K, Garcia MIM, Cerutti E, Lisanti I, Draisci G, Frassanito L, et al. Intraoperative hypotension when using hypotension prediction index software during major noncardiac surgery: a European multicentre prospective observational registry (EU Hyprotect). BJA Open. 2023 May 4;6:100140.

Important safety information

CAUTION: Federal (United States) law restricts this device to sale by or on the order of a physician.
See Instructions For Use (IFU) / Directions For Use (DFU) for full prescribing information, including indications, contraindications, warnings, precautions and adverse events.